/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

Immunovant Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$22.48 0.0313(3.13%) IMVT at 04 Dec 2025 04:35 PM Biotechnology
Lowest Today 22.25
Highest Today 23.06
Today’s Open 22.25
Prev. Close 22.02
52 Week High 29.49
52 Week Low 12.72
Day’s Range: Low 22.25 High 23.06
52-Week Range: Low 12.72 High 29.49
1 day return -
1 Week return -5.95
1 month return -6.03
3 month return +40.89
6 month return +48.33
1 year return -20.35
3 year return +58.35
5 year return -53.05
10 year return -

Institutional Holdings

FMR Inc 10.67

Deep Track Capital, LP 5.45

Vanguard Group Inc 4.03

T. Rowe Price Investment Management,Inc. 3.95

Fidelity Growth Compy Commingled Pl S 3.87

BlackRock Inc 3.36

Baker Bros Advisors LP 3.13

Armistice Capital, LLC 2.98

Fidelity Growth Company Fund 2.76

Point72 Asset Management, L.P. 1.91

State Street Corp 1.62

Alpine Partners VI, LLC 1.51

T. Rowe Price US Small-Cap Core Equity 1.46

T. Rowe Price Small-Cap Stock 1.41

Morgan Stanley - Brokerage Accounts 1.32

Two Seas Capital LP 1.29

Perceptive Advisors LLC 1.23

Vanguard Total Stock Mkt Idx Inv 1.22

Geode Capital Management, LLC 1.05

Vanguard Small Cap Index 0.95

iShares Russell 2000 ETF 0.94

Woodline Partners LP 0.86

Fidelity Growth Company K6 0.84

StemPoint Capital LP 0.75

SPDR® S&P Biotech ETF 0.74

T. Rowe Price Instl Small-Cap Stock 0.72

T. Rowe Price U.S. SC Core Eq Tr-D 0.72

Fidelity Series Growth Company 0.72

Goldman Sachs Group Inc 0.69

Pictet Asset Manangement SA 0.68

Fidelity Select Health Care 0.63

Vanguard Small Cap Value Index Inv 0.62

Aberdeen Group PLC 0.48

Vanguard Institutional Extnd Mkt Idx Tr 0.48

FIAM Small Cap Core Composite 0.42

Fidelity Select Biotechnology 0.40

NORGES BANK 0.39

Fidelity Small Cap Index 0.39

abrdn Healthcare Investors 0.37

T. Rowe Price Small-Cap Value 0.36

Market Status

Strong Buy: 10

Buy: 3

Hold: 1

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 3859.59 M

PB Ratio 8.1449

PE Ratio 0.0

Enterprise Value 3519.06 M

Total Assets 776.22 M

Volume 1043165

Company Financials

Annual Revenue FY25:0 0.0M, FY24:0 0.0M, FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M

Annual Profit FY25:-377000 -0.4M, FY24:-231000 -0.2M, FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M

Annual Net worth FY25:-413840000 -413.8M, FY24:-259336000 -259.3M, FY23:-210960000 -211.0M, FY22:-156730000 -156.7M, FY21:-107431000 -107.4M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:160000 0.2M, Q4/2024:0 0.0M, Q3/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:-107000 -0.1M, Q1/2025:80000 0.1M, Q4/2024:null 0.0M, Q3/2024:null 0.0M

Quarterly Net worth Q3/2025:-126502000 -126.5M, Q2/2025:-120613000 -120.6M, Q1/2025:-106449000 -106.4M, Q4/2024:-111122000 -111.1M, Q3/2024:-109119000 -109.1M

Fund house & investment objective

Company Information Immunovant, Inc., a clinical-stage immunology company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops IMVT-1402 for graves' disease, rheumatoid arthritis, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, cutaneous lupus erythematosus disease, and sjögren's disease; and batoclimab for myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and thyroid eye disease. The company was founded in 2018 and is based in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.

Organisation Biotechnology

Employees 362

Industry Biotechnology

CEO Dr. Eric Venker M.D., Pharm.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow